Product Search

#10151 Anti-Human Presenilin-1 (17C2) Mouse IgG MoAb

  • WB
  • Human brain(Altzheimer's Disease)
Intended Use:
Research reagents
Application:
WB, IHC
Package Size1:
200 μg
Note on Application Abbreviations
WB:Western Blotting
IHC:Immunohistochemistry

※ The product indicated as "Research reagents" in the column Intended Use cannot be used
  for diagnostic nor any medical purpose.
※ The datasheet listed on this page is sample only. Please refer to the datasheet
  enclosed in the product purchased before use.

Product Overview

Product Overview

Product Code 10151
Product Name Anti-Human Presenilin-1 (17C2) Mouse IgG MoAb
Intended Use Research reagents
Application WB, IHC
Species Human
Immunizing antigen N-terminal fragment of recombinant Human Presenilin-1 (E. coli)
Source Mouse-Mouse hybridoma (X63 - Ag 8.653 × BALB/c mouse spleen cells, supernatant)
Clone Name 17C2
Subclass IgG1
Purification Method Affinity purified with ProteinA
Specificity Human Presenilin-1 specific, non-cross react with Human Presenilin-2
Package Form Lyophilized product from 1 % BSA in PBS containing 0.05 % NaN3
Storage Condition 2 - 8℃
Poisonous and Deleterious Substances Applicable
Cartagena Not Applicable
Package Size 1 200 μg
Remarks1 The commercial use of products without our permission is prohibited. Please make sure to contact us and obtain permission.

Product Description

Product Description

The presenilin 1 (PS1) gene was identified as the gene that harbors mutations that cause this type of FAD (termed AD3). PS1 is a novel 467-aa long integral membrane protein localized to intracellular membranous compartments, especially the endoplasmic reticulum, that spans the membrane 7-9 times. More than 30 missense mutations or amino acid deletions have been identified in a number of AD3 pedigrees. Shortly after the discovery of PS1, the gene responsible for FAD was found on chromosome 1. This gene is known as PS2 and it is highly homologous to PS1 (67% identical). Sequence analysis predicts integral membrane proteins, which contain seven putative transmembrane domains, a short hydrophilic amino- and carboxyl-terminal tail, and a large hydrophilic loop between the sixth and seventh membrane-spanning domain. All of reported mutation that results in early-onset Alzheimer’s disease are missense mutations, 24 in PS1 and two in PS2, or mutations that affect the splicing without affecting the coding of the protein and this has led the hypothesis that they may result in a gain of (miss) function.

FAQ

FAQ

  • Question
    Q.Can this antibody be used on mice or rat samples ?
  • Answer
    A.No it cannot.
  • Question
    Q.Does the antibody cross react to mice?
  • Answer
    A.No, it doesn't.